Global Glaucoma Therapeutics Market Size By Drug Class (Beta-Blockers, Prostaglandin Analogues), By Disease Indication (Open Angle Glaucoma, Angle Closure Glaucoma), By Distribution Channel (Online Pharmacy, Retail Pharmacy), By Geographic Scope And Forecast

Glaucoma Therapeutics Market Size And Forecast

Glaucoma Therapeutics Market size was valued at USD 6.95 Billion in 2022 and is projected to reach USD 11.54 Billion by 2030 growing at a CAGR of 5.90% from 2023 to 2030.

The Glaucoma Therapeutics Market is growing due to the growing prevalence of glaucoma, advancements in diagnostic technologies, the growing geriatric population, increasing healthcare expenditure, and favorable reimbursement policies. Additionally, technological advancements in glaucoma therapeutics, such as minimally invasive glaucoma surgery (MIGS) devices, sustained-release drug delivery systems, and the availability of new drug formulations, are driving the market growth. The Global Glaucoma Therapeutics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Glaucoma Therapeutics Market Definition

Glaucoma is an eye condition that causes damage to the optic nerve, a nerve that links the eye to the brain. It is frequently associated with increased intraocular pressure (pressure within the eye) but can also occur without raised pressure. Glaucoma is a primary cause of permanent blindness affecting millions globally. Some types of glaucoma are primary open-angle glaucoma, angle-closure glaucoma, normal-tension glaucoma, and secondary glaucoma. The condition often progresses slowly without symptoms in the early stages, leading to gradual vision loss; if left untreated, the condition causes permanent blindness. The primary diagnosis for the condition is regular eye pressure measurement and examination of the optic nerve.

The common therapeutics for the condition are medications, laser therapy, surgery, and minimally invasive glaucoma surgery. These therapies help to diagnose and treat the condition effectively. The treatment choice usually depends on the severity and type of glaucoma, the patient’s reaction to treatment, and individual characteristics such as age, general health, and lifestyle. Typically, the treatment plans are tailored according to the specific needs of the patients and include a combination of medications, surgery, and laser therapy.

Global Glaucoma Therapeutics Market Overview

The increasing prevalence of glaucoma is a key factor that is attributed to driving the market growth. For instance, according to Glaucomapatients.org, glaucoma is the most common cause of permanent blindness, with approximately 13% of the patients suffering from permanent blindness due to the condition. As of 2020, an estimated 79.6 million people globally suffered from the condition. The condition’s prevalence is expected to increase considerably, wherein more than 111 million people suffering by 2040.

The article also states half of the patients are unaware of the condition. The detection rate of the condition in developing nations is further low, with 90% of glaucoma conditions being undetected. The main factor contributing to the rising prevalence of the condition is the rapidly growing geriatric population. The geriatric population is at a considerably high risk of suffering from the condition. For instance, according to an article by CDC, 6% of the population between the age of 65-69 years suffered from glaucoma, while the number increased to 17% for adults above 85 years.

Advancements in diagnostic technology are a critical factor driving the growth in the glaucoma treatments industry. Technologies like optical coherence tomography (OCT) and visual field testing have made glaucoma identification and monitoring more accurate, resulting in increased awareness and diagnostic rates and a greater need for glaucoma therapies. Optical Coherence Tomography (OCT) is a non-invasive imaging technique used to diagnose, treat, and monitor glaucoma. It provides detailed images of structural abnormalities in the eye associated with glaucoma by providing comprehensive cross-sectional pictures of the optic nerve head, retina, and retinal nerve fiber layer (RNFL).

Additionally, the advancements in minimally invasive surgeries are attributed to driving the market growth. The adoption of minimally invasive surgeries is rising due to the fewer incisions, low costs, and faster recovery than traditional surgeries. Favorable reimbursement policies are attributed to driving the adoption of glaucoma therapies. Reimbursement assistance for glaucoma treatments encourages patients to seek treatment as soon as possible and provides access to modern medicines. This reduces budgetary obstacles and enhances glaucoma therapeutic uptake.

Global Glaucoma Therapeutics MarketSegmentation Analysis

The Global Glaucoma Therapeutics Market is Segmented on the basis of Drug Class, Disease Indication, Distribution Channel, And Geography.

Glaucoma Therapeutics Market, By Drug Class

• Beta-Blockers
• Prostaglandin Analogues
  1. Latanoprost
  2. Bimatoprost
  3. Travoprost
  4. Others
• Alpha Adrenergic Agonists
• Carbonic Anhydrase Inhibitors
• Combination Drugs
• Others

Based on Drug Class, The market is segmented into Beta-Blockers, Prostaglandin Analogues, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Combination Drugs, and Others. The Prostaglandins Analogs are further segmented into Latanoprost, Bimatoprost, Travoprost, and Others. The Prostaglandins Analogs segment accounted for the largest market share in 2022 owing to the drug’s high efficacy in reducing intraocular pressure compared to other drug classes. The drug is also used as a first line of treatment to treat glaucoma and is considered highly effective in managing the condition.

Glaucoma Therapeutics Market, By Disease Indication

• Open Angle Glaucoma
• Angle Closure Glaucoma
• Others

Based on Disease Indication, the market is segmented into Open Angle Glaucoma, Angle Closure Glaucoma, and Others. The Angle Closure Glaucoma segment accounted for the largest share in 2022 owing to the rising prevalence of the condition compared to other types of glaucoma. For instance, according to nih.gov, more than 6.48 million people over 40 suffer from the condition in India.

Glaucoma Therapeutics Market, By Distribution Channel

• Online Pharmacy
• Retail Pharmacy
• Hospital Pharmacy

Based on Distribution Channel, The market is segmented into Online Pharmacy, Retail Pharmacy, and Hospital Pharmacy. The nuclear Hospital Pharmacy segment accounted for the largest market share in 2022. The segment growth is due to the growing number of people undergoing glaucoma therapies at the hospitals. Despite this, the retail pharmacy segment is anticipated to grow lucratively due to the increasing preference of patients, especially the geriatric population to undergo treatments in outpatient settings.

Glaucoma Therapeutics Market, By Geography

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

On the basis of Geography, the Global Glaucoma Therapeutics Market is classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America dominated the market in 2022. Key factors driving the market growth are technologically advanced diagnosis and treatment infrastructure in hospitals and healthcare facilities and favorable reimbursement policies for therapies. Despite this, Asia Pacific is anticipated to grow lucratively due to the growing geriatric population in countries such as China and Japan. Additionally, governments in countries such as India are taking adequate measures to improve awareness about the condition among the population, which is expected to drive market growth.

Key Players

The “Global Glaucoma Therapeutics Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Merck & Co., Inc., Novartis AG, AbbVie Inc., Bausch and Lomb Incorporated, Teva Pharmaceuticals Industry, Pfizer, Inc., Aerie Pharmaceuticals, and Inotek Pharmaceuticals.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

• In July 2022, AbbVie announced a strategic partnership with iSTAR Medical wherein the companies will work towards commercialization of MINIject® device, a minimally invasive glaucoma surgical device for patients suffering from glaucoma.
• In April 2022, Sandoz, a Novartis subsidiary, announced the launch of a generic version of Combigan, a popular combination of eye drops used to treat increased eye pressure.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Glaucoma Therapeutics Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Global Glaucoma Therapeutics Market, gauge the attractiveness of a particular sector, and assess investment possibilities.

Report Scope

Top Trending Reports

Research Methodology of Market Research